Plague Vaccine or Diagnostics
- Technology Benefits
- A vaccine developed with this technology will target a surface protein required for the virulence of Yersinia pestis and is non-pathogenic
- Technology Application
- Vaccine development against plague; adjuvant to enhance immunogenicity in a vaccine; detection and diagnosis of plague infection
- Detailed Technology Description
- This patented technology exploits one of the proteins composing the pathogenic structure of Yersinia pestis. The recombinant protein or its derivatives can be used as an antigen to develop a novel vaccine for immunization against the plague.
- *Abstract
-
This technology relates to recombinant protein products that are useful as antigens for development of antibody in a plague diagnostics or vaccine preparation.
- Country/Region
- USA
For more information, please click Here
